Postpartum Depression: A Significant Burden and a Novel Approach to Treatment - a podcast by ReachMD

CME credits: 0.50

Valid until: 05-12-2024

Claim your CME credit at https://reachmd.com/programs/cme/postpartum-depression-a-significant-burden-and-a-novel-approach-to-treatment/15685/

The recent development and approval of two neuroactive steroids is likely to change the treatment paradigm for moderate to severe postpartum depression (PPD). These agents have a quick onset and function as GABAA positive allosteric modulators. Join Drs. Shulman and Deligiannidis as they address the burdens and impacts of PPD on mothers, babies, and partners, and deep dive into the pathophysiologic role and clinical findings associated with the use of neuroactive steroids in the management of PPD.

=

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD